Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00800540 |
Compare the short term effects of two IOP-lowering medications on ocular perfusion pressure, ocular blood flow, circadian IOP and blood pressure in patients with glaucoma.
Condition | Intervention | Phase |
---|---|---|
Glaucoma |
Drug: AZARGA Drug: COMBIGAN |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Crossover Assignment |
Estimated Enrollment: | 36 |
Study Start Date: | November 2008 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
AZARGA
|
Drug: AZARGA
Brinzolamide 10 mg/ml / Timolol 5 mg/ml, Eye drops, suspension
|
2: Active Comparator
COMBIGAN
|
Drug: COMBIGAN
Brimonidine 2 mg/ml / Timolol 5 mg/ml, Eye drops, solution
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Alcon ( Severine Durier/Study Manager ) |
Study ID Numbers: | C-07-16, eudract Number 2007-005936-99 |
Study First Received: | December 1, 2008 |
Last Updated: | December 1, 2008 |
ClinicalTrials.gov Identifier: | NCT00800540 History of Changes |
Health Authority: | United States: Institutional Review Board |
glaucoma ocular perfusion pressure ocular blood flow open angle glaucoma requiring more than one IOP-lowering medication |
Brinzolamide Glaucoma Eye Diseases Glaucoma, Open-Angle Timolol |
Tetrahydrozoline Brimonidine Hypertension Ocular Hypertension |
Glaucoma Eye Diseases Ocular Hypertension |